Introduction On Monday, November 16, 2015 around 3:30pm I got to interview my mentor Ken Diffenderfer the Lab Manager of the Stem Cell Core. I have been interning at the Salk Institute for five months so this was not a scary task to do however it didn’t turn out like a normal interview. We started off facing each other and talking in the entrance of the lab. However we quickly moved to the hoods where we could work on our cell culture and talk. From question two on our conversation flowed from topic to topic seamlessly as we worked on our experiments. Questions 1. What is your position and what do you do? What problems do you face with this job? As the Lab Manager of the Stem Cell Core, I am responsible for general lab material such as media and supplies, making sure all the cells we supply are available. This includes taking inventory. My favorite part of my job is the training. As a Core facility our job is to help other researchers complete their projects. I do hands on intro training for the new users (what we call the researchers that use the stem cell core), and am available for basic project support. I don’t like thinking of problems… I guys you could say it’s hard to prioritize everything that has to get done in the day, while making time …show more content…
Academia is working at research institutions and universities versus industry which is working in a business focused on a certain disease, invention or cure. Academia tends to pay less, unless you have a name for yourself, which you by publishing papers and by making discoveries. Academia salary ranges are as follows: with bachelor’s degree you can make between $35-55,000, with a master’s you can make $45-65,000 and with a PhD you can make $80,000+. Ken did not know the comparisons to industry so I looked this up. In industry add $10,000 to a bachelor’s degree salary, add $20,000 to masters’ degree and have the starting salary be a $95-105,000 for a
Think for a moment. Imagine the cure for Alzheimer’s, Parkinson’s, heart disease, spinal injuries and almost every other cruel disease being at the world’s fingertips, but no further research is being done to interpret the use of these treatments. The miracle cure for many terminal illnesses is embryonic stem cells, which are in theory nothing but a ball of around 100-150 cells, yet numerous countries across the world have made their use illegal because it is ‘unethical’.
I develop HIPAA compliance report, document auditing findings and develop corrective action plans or a POAM for the system as needed.
I am responsible for the development of staff and support them to perform their roles. I conduct monthly one to one meetings and identify any training needs. I organise training, sourcing suitable courses from the internal Shared Service System where courses are listed, and from local colleges and local service providers to suit the training need.
"I think this marks the beginning of a new era for stem cell research," Robert Lanza, the company's chief scientific officer, wrote in an email. "After a decade of intense controversy, the field is finally ready to prove itself--and to actually start helping patients suffering from a range of horrific diseases. It also shows the new readiness of the FDA to work with researchers to move exciting new stem cell therapies out of the laboratory and into the clinic." Later this month they plan on cluding and gathering the result of the
Figure 3 is difficult to interpret because it seems to be missing a group. What group seems to be missing? How would the inclusion of this group aid in the interpretation of this figure?
In fact, just three months ago I recommended Verastem, Inc. NASDAQ Stock Symbol – VSTM, a best performer developer of drugs targeting cancer stem cells amongst all NYSE and NASDAQ listed stocks in the health care sector in late September.
In August 2010, Hannah Warren, a Korean baby girl was born with no windpipe. When Hannah was delivered, she was blue, and her doctors had to force a tube down her throat so she could breathe properly. Following some tests, the doctors found that Hannah had been born without a trachea. Hannah’s parents were told most children in her condition didn’t survive, and that she had a very low chance as well. However, she continued to grow bigger and stronger, and her family kept searching the internet for possible treatments. The family found information concerning stem cells and their use in regenerative medicine, and learned about a physician who was creating windpipes out of stem cells and transplanting them into patients. The family got into
I am the Lead Specialist in the processing area of the laboratory I work in. This area is very busy as we handle every specimen that comes into the laboratory for testing. The responsibility of ensuring that every item brought in for testing is properly handled, ordered, and distributed is up to us. My job is stressful at times, but I am very proud to be a part of a team that comes together every day to allow the patients we serve to get the best care possible.
Stem-cell research is a very interesting and controversial topic that many authors and scientists take time to write about. Christopher Robertson is one such author, who wrote the article “Recent Developments in the Law and Ethics of Embryonic Research: Can Science Resolve the Ethical Problems it Creates”. Robertson provides readers with the information they are looking for and the article has merit as an example of technical writing. This article discusses three main topics: the legal background, how scientific progress can resolve ethical issues, and assessing alternative methods of stem-cell research. By analyzing the three main sections it is possible to see the merit of this article.
We’ve all heard about stem cells, right? From the news, to website ads, stem cells are brought up. So, what exactly do they do, and how do they do it?
1. Please tell me about yourself. What do you do for a living, and how did you become involved in your line of work?
Human Embryonic stem cells have the capacity to be come any cell in the body. This means that they have a multiple of potential, which makes them pluripotent. There are four types of pluripotent stems cells. Three of which require eggs to create. The most commonly understood is the embryonic stem cell. It comes from an egg which was fertilized by a sperm. In 2007 scientists developed a new way of developing pluripotent stem cells without the need or use for a human egg. Research has revealed that only a few of the more than 20,000 protein that are encoded in the genes of the ESC were responsible or the stem cell characteristics of pluripotency and self-renewal. In the paper, the journal, Induced Pluripotent Stem Cells: Generation Strategy and
Stem Cells: What, How and Why? Stem cells are infinitely valuable when considering their potential applications in the medical profession. While current legislative restrictions have halted the development of new ?stem cell lines? to any agency or company that receives any form of governmental grants, there is no question that the medical profession is standing at the brink of a new era of technological advancements in healthcare and research.
Stem cells are located deep down in our bone marrow. They have the incredible ability of “generating an endless supply of red cells, white cells, and platelets”(1). They have been called the “Mother of all blood cells” due to their ability to regenerate the entire blood supply of a persons body. Just to think that this is possible is actually pretty incredible. The man who claims to be responsible for the discovery of this gem is a immunologist from Stanford University named Irving Weissman, and his collaborators at SyStemix, (a biotech company that he cofounded in 1988, located in Palo Alto, CA). He and his company are so
Because of the friction caused by the stem cells source, stem cell research was delayed for many years, occasionally they would be supported for a short time, only to be shut down again. It wasn’t until very recently, March 9, 2009 in fact, that President Barrack Obama lifted one of the previous president’s executive order to halt stem cell research involving human stem cells. Putting the ethical concerns aside, another, perhaps more